Latest News and Press Releases

Richland WA, July 09, 2019 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCPINK: RDGLD) Vivos, Inc. is pleased to announce that Vista Veterinary Hospital has completed its first Isopet® certification training...

Richland WA, July 02, 2019 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCPINK: RDGLD), Vivos today announced the filing of a patent application covering key aspects of its technology and propriety...

Richland, WA, June 27, 2019 (GLOBE NEWSWIRE) -- Vivos Inc. (the “Company”) (OTC PINK: RDGL), a company engaged in the development and commercialization of minimally invasive brachytherapy...

Richland, WA, June 26, 2019 (GLOBE NEWSWIRE) -- Vivos Inc. (the “Company”) (OTC PINK: RDGL), a company engaged in the development and commercialization of minimally invasive brachytherapy...

Richland WA, June 18, 2019 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCPINK: RDGL), Vista Veterinary Hospital obtained their license to administer IsoPet® for animal therapy from the state of Washington. ...

Richland WA, April 30, 2019 (GLOBE NEWSWIRE) -- Vivos Inc. (OTCPINK: RDGL), provides an update on the progress towards commercialization of Y-90 IsoPet® for animal therapy. Animal...

Richland WA, March 04, 2019 (GLOBE NEWSWIRE) -- Vivos, Inc. (OTCPINK: RDGL), provides a summary of the previous update on dogs that have been treated to date in the canine soft tissue sarcoma...

Richland WA, Feb. 25, 2019 (GLOBE NEWSWIRE) -- Vivos, Inc. (OTC PINK: RDGL) Vivos Inc. (OTCPINK: RDGL), a pharmaceutical company in the process of researching and developing minimally invasive...

Richland WA, Feb. 01, 2019 (GLOBE NEWSWIRE) -- Vivos, Inc. (OTC PINK: RDGL). The Board of Directors of Vivos Inc. (OTCPINK: RDGL), a pharmaceutical company in the process of researching and...

Richland WA, Jan. 11, 2019 (GLOBE NEWSWIRE) -- Vivos, Inc. (OTCPINK: RDGL), announced that the device classification obtained from the FDA Center for Veterinary Medicine (CVM) is not limited to...